3 Year Absolute Returns
81.72% ↑
NAV (₹) on 29 Sep 2026
37.46
1 Day NAV Change
-0.20%
Risk Level
Very High Risk
Rating
-
LIC MF Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by LIC Mutual Fund Asset Management Limited. Launched on 08 Feb 2019, investors can start with a minimum ... Read more
AUM
₹ 103.11 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 63.69% |
| Hospitals & Medical Services | 29.16% |
| Chemicals - Others | 5.65% |
| Treps/Reverse Repo | 1.58% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.09% | ₹ 10.41 | Pharmaceuticals |
| Divi's Laboratories Ltd. | 9.29% | ₹ 9.58 | Pharmaceuticals |
| Torrent Pharmaceuticals Ltd. | 6.45% | ₹ 6.65 | Pharmaceuticals |
| Neuland Laboratories Ltd. | 6.38% | ₹ 6.58 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.23% | ₹ 6.42 | Hospitals & Medical Services |
| Navin Fluorine International Ltd. | 5.65% | ₹ 5.83 | Chemicals - Others |
| Aurobindo Pharma Ltd. | 5.17% | ₹ 5.33 | Pharmaceuticals |
| Aster DM Quality Care Ltd. | 4.82% | ₹ 4.97 | Hospitals & Medical Services |
| Zydus Lifesciences Ltd. | 4.79% | ₹ 4.94 | Pharmaceuticals |
| Gland Pharma Ltd. | 3.93% | ₹ 4.05 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 3.78% | ₹ 3.90 | Hospitals & Medical Services |
| Global Health Ltd. | 3.19% | ₹ 3.29 | Hospitals & Medical Services |
| IPCA Laboratories Ltd. | 3.18% | ₹ 3.28 | Pharmaceuticals |
| Metropolis Healthcare Ltd. | 3.17% | ₹ 3.27 | Hospitals & Medical Services |
| Cohance Lifesciences Ltd. | 2.92% | ₹ 3.01 | Pharmaceuticals |
| Mankind Pharma Ltd. | 2.89% | ₹ 2.98 | Pharmaceuticals |
| Artemis Medicare Services Ltd. | 2.88% | ₹ 2.97 | Hospitals & Medical Services |
| Glenmark Pharmaceuticals Ltd. | 2.88% | ₹ 2.97 | Pharmaceuticals |
| Max Healthcare Institute Ltd. | 2.55% | ₹ 2.63 | Hospitals & Medical Services |
| Biocon Ltd. | 2.54% | ₹ 2.62 | Pharmaceuticals |
| Dr Agarwal's Health Care Ltd. | 2.54% | ₹ 2.62 | Hospitals & Medical Services |
| Onesource Specialty Pharma Ltd. | 2.21% | ₹ 2.28 | Pharmaceuticals |
| Treps | 1.58% | ₹ 1.63 | Others |
| Syngene International Ltd. | 0.97% | ₹ 1 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 17.91% | 18.38% | 7.98% | 22.03% |
| Category returns | 2.92% | 5.01% | 0.90% | 19.28% |
The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹37.91 | 126.98% | 329.43% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹37.91 | 126.98% | 329.43% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹37.91 | 126.98% | 329.43% | 0.00% | ₹1,128 | 1.12% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.37 | 123.95% | 312.07% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.37 | 123.95% | 312.07% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹35.37 | 123.95% | 312.07% | 0.00% | ₹1,128 | 2.40% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.35 | 25.00% | 153.55% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.35 | 25.00% | 153.55% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.35 | 25.00% | 153.55% | 0.00% | ₹11,478 | 0.89% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.26 | 23.79% | 145.46% | 0.00% | ₹11,478 | 1.78% |
Very High
|
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
LIC MF Gold ETF
ETF
Regular
|
₹131.77 | 27.19% | 149.50% | 209.59% | ₹1,500 | 0.45% |
High
|
|
LIC MF Gold ETF FOF - Direct Plan
Fund of Funds
Direct
|
₹39.83 | 25.28% | 145.01% | 203.15% | ₹858 | 0.35% |
High
|
|
LIC MF Gold ETF FOF
Fund of Funds
Regular
|
₹37.65 | 24.92% | 142.26% | 197.31% | ₹858 | 0.61% |
High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹62.43 | 10.99% | 86.11% | 166.70% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹61.29 | 10.99% | 85.98% | 165.58% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Infrastructure Fund - Direct Plan
Sector
Direct
|
₹61.29 | 10.99% | 85.98% | 165.58% | ₹1,174 | 1.35% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.47 | 18.39% | 81.77% | 83.51% | ₹103 | 1.42% |
Very High
|
|
LIC MF Healthcare Fund - Direct Plan
Sector
Direct
|
₹37.46 | 18.38% | 81.72% | 83.45% | ₹103 | 1.42% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹53.74 | 9.51% | 78.90% | 150.64% | ₹1,174 | 2.69% |
Very High
|
|
LIC MF Infrastructure Fund
Sector
Regular
|
₹53.74 | 9.51% | 78.90% | 150.63% | ₹1,174 | 2.69% |
Very High
|
What is the current NAV of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the fund size (AUM) of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What are the historical returns of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the risk level of LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
What is the minimum investment amount for LIC MF Healthcare Fund - Direct Plan IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article